Description
Epithalon SC Reusable Injection – 120 mg – 4 × 30 mg Cartridges is a peptide formulation supplied in a reusable injection system with four individual cartridges.
Epithalon has been investigated in scientific research relating to cellular signaling, biological ageing processes and other areas of peptide research. The cartridge-based system provides a convenient format for professional-use protocols where an appropriate reusable administration device is specified.
Key Features
- Epithalon peptide formulation
- 120 mg total peptide
- 4 × 30 mg cartridges
- Reusable injection system
- Consistent cartridge-based presentation
- Intended for professional-supervised use
⚗️ Composition
- Active ingredient: Epithalon
- Total amount: 120 mg
- Cartridge quantity: 4
- Amount per cartridge: 30 mg
- Form: Peptide cartridge formulation
- Presentation: Reusable SC injection system
💉 Administration
- Intended for subcutaneous administration where specifically prescribed or authorised.
- Administration should be performed according to the manufacturer’s instructions and under appropriate professional supervision.
📊 Dosage Information
The supplier-provided pen system is calibrated at 0.1 mg per click.
Practitioner-directed protocol:
- 50 clicks once daily
- Duration: 20 consecutive days
Dosage, administration technique, suitability and treatment duration should be determined and supervised by a qualified healthcare professional.
⚠️ Important Information
- Professional-use peptide product.
- Use only under appropriate healthcare-professional supervision.
- Follow the manufacturer’s instructions for the reusable device and cartridges.
- Not intended for self-diagnosis or unsupervised treatment.
- Keep out of reach of children.
🧊 Storage Instructions
Store according to the specific storage conditions supplied with the product/cartridges. Protect from excessive heat, direct sunlight and contamination. Do not freeze unless the manufacturer’s instructions specifically state otherwise.












Reviews
There are no reviews yet.